Medication info
Ciprofloxacin Tablets 250mg (Ciprofloxacin Hydrochloride Monohydrate)

Ciprofloxacin Tablets 250mg (Ciprofloxacin Hydrochloride Monohydrate)

Prescription medicationTabletOral
Ingredient · strength
Ciprofloxacin Hydrochloride Hydrate›291mg / 1 tablet
Manufacturer / importer
Eden Pharma Co., Ltd.
Appearance
White round film-coated tablets
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 201800299 · Approved 2018.01.23 · Insurance code 628900970

Summary

Main use
Treatment of bacterial infections (urinary tract, respiratory tract, gastrointestinal tract, etc.)
Who takes it
Adults
Adult dose
○ Usual adult dosage: Administer 250 ~ 500 mg of ciprofloxacin orally twice daily between meals. For severe complicated infections, the dose may be increased to 750 mg twice daily. For acute infections, treatment is usually given for 5 ~ 10 days, and continued for at least 3 days after symptoms have resolved. ○ Patients with renal impairment 1) Creatinine clearance > 50 mL/min: Administer the usual dose 2) 30 ~ 50 mL/mn: Administer 250 ~ 500 mg twice daily 3) 5 ~ 29 mL/min: Administer 250 ~ 500 mg every 18 hours 4) Patients receiving hemodialysis or peritoneal dialysis: Administer 250 ~ 500 mg once daily after dialysis 5) If only serum creatinine is known, creatinine clearance can be calculated using the following formulas. Men: {body weight (kg) × (140-age)}/ {72 × serum creatinine (mg/dL)} Women: 0.85 × the value calculated for men 6) For severe infections, the dose may be increased to 750 mg per dose even in patients with severe renal impairment; however, the patient's condition should be monitored carefully after administration. Dosage may be adjusted according to symptoms.

Ingredients

Manufacturer
Eden Pharma Co., Ltd.

Efficacy & effects

Treatment of bacterial infections (urinary tract, respiratory tract, gastrointestinal tract, etc.)

  • Acute bronchitis
  • respiratory infections
  • community-acquired pneumonia
  • pharyngitis
  • tonsillitis
  • laryngitis
  • otitis externa
  • chronic cholesteatomatous otitis media
  • chronic otitis media
  • bacterial prostatitis
  • acute simple cystitis
  • acute pyelonephritis
View approved original text

This medication is used to treat various infections caused by bacteria such as Escherichia coli, Shigella, and Salmonella. It is effective for respiratory infections other than acute bronchitis and community-acquired pneumonia, and is also applicable for infections related to the ear, nose, and throat. Additionally, it is used for the treatment of bacterial prostatitis, urinary tract infections, gonococcal cervicitis, and urethritis. It is also effective for gastrointestinal infections, infections of the bile ducts, skin and soft tissue infections, and infections of bone and joints. It is utilized for treating gynecological infections, peritonitis, as well as infections such as dacryocystitis and hordeolum around the eyes. However, this medication may have the potential for serious adverse reactions and should be used only when there are no alternative treatments for specific infections. This medication is used to treat various bacterial infections.

How to take

Adult dose

○ Usual adult dosage: Administer 250 ~ 500 mg of ciprofloxacin orally twice daily between meals. For severe complicated infections, the dose may be increased to 750 mg twice daily. For acute infections, treatment is usually given for 5 ~ 10 days, and continued for at least 3 days after symptoms have resolved. ○ Patients with renal impairment 1) Creatinine clearance > 50 mL/min: Administer the usual dose 2) 30 ~ 50 mL/mn: Administer 250 ~ 500 mg twice daily 3) 5 ~ 29 mL/min: Administer 250 ~ 500 mg every 18 hours 4) Patients receiving hemodialysis or peritoneal dialysis: Administer 250 ~ 500 mg once daily after dialysis 5) If only serum creatinine is known, creatinine clearance can be calculated using the following formulas. Men: {body weight (kg) × (140-age)}/ {72 × serum creatinine (mg/dL)} Women: 0.85 × the value calculated for men 6) For severe infections, the dose may be increased to 750 mg per dose even in patients with severe renal impairment; however, the patient's condition should be monitored carefully after administration. Dosage may be adjusted according to symptoms.

Precautions

This medication may cause serious side effects such as tendinitis or tendon rupture, so it should be discontinued immediately if these symptoms appear. In particular, patients with myasthenia gravis should avoid this medication as it may worsen their symptoms. Pregnant or breastfeeding women, children under 18, patients with epilepsy, those allergic to this medication, or patients who have a history of tendinitis or tendon rupture should not take it. Additionally, serious side effects may occur when used in conjunction with certain medications, so it is crucial to inform your doctor or pharmacist of any other medications you are currently taking. This medication should be used with caution in patients with impaired renal function, the elderly, and patients with a history of seizures. While taking this medication, symptoms such as seizures, dizziness, mental disturbances, severe diarrhea, skin rashes, myalgia, and visual disturbances may occur; if any of these symptoms appear, you should consult a healthcare professional immediately. This medication may increase sensitivity to sunlight, thus during treatment, strong sunlight or exposure to artificial UV rays should be avoided, and appropriate protective measures should be taken when necessary. Diabetic patients requiring blood sugar control should frequently check their blood glucose levels as hypoglycemia or hyperglycemia may occur. This medication has a high potential for drug interactions, particularly if taken with anticoagulants, diabetes medications, immunosuppressants, and certain pain relievers, so caution is advised. In case of overdose, kidney damage may occur, thus the prescribed dosage should be strictly followed, and doses should not be increased without a doctor's instruction. Store in a place away from children's reach, protecting it from direct sunlight and UV exposure.

Side effects

Tendinitis, tendon rupture, peripheral neuropathy, central nervous system effects, exacerbation of myasthenia gravis, fungal superinfection, antibiotic-associated colitis, eosinophilia, thrombophlebitis, leukopenia, anemia, neutropenia, leukocytosis, thrombocytopenia, thrombocytosis, erythrocytopenia, reduced hemoglobin, reduced hematocrit, granulocytopenia, leukolysis, hemolytic anemia, agranulocytosis, pancytopenia, bone marrow suppression, increased INR value, syndrome of inappropriate antidiuretic hormone secretion, allergic reactions, allergic edema, angioedema, anaphylaxis, anaphylactic shock-like reaction, serum sickness-like reaction, decreased appetite, reduced food intake, increased serum alkaline phosphatase, hyperglycemia, hypoglycemia, increased lipase, abnormal prothrombin levels, increased amylase, psychomotor agitation, anxiety, confusion, disorientation, emotional instability, abnormal dreams, depression, hallucinations, psychotic reactions, toxic psychosis, headache, dizziness, sleep disorders, taste disorders, insomnia, sensory abnormalities, sensory loss, loss of taste, tremors, spasms, vertigo, altered mental state, seizures, drowsiness, migraine, coordination disorders, olfactory disorders, hyposmia, sensory hypersensitivity, increased intracranial pressure, ataxia, peripheral neuropathy, polyneuropathy, vision disorders, chromatic vision, double vision, tinnitus, hearing loss, transient hearing loss, hearing impairment, tachycardia, vasodilation, hypotension, syncope, vasculitis, QT prolongation, ventricular tachycardia, Torsades de Pointes, dyspnea, laryngeal edema, nausea, diarrhea, anorexia, dyspepsia, vomiting, gastrointestinal and abdominal pain, abdominal distension, dyspepsia, colitis with blood in stool, stomatitis, oral candidiasis, gastrointestinal candidiasis, pancreatitis, abnormal liver function tests, increased bilirubin, liver dysfunction, jaundice, hepatitis, cholestatic jaundice, liver necrosis, rash, itching, urticaria, photosensitivity, vesicles, petechiae, erythema multiforme, toxic epidermal necrolysis, fixed drug eruption, acute generalized exanthematous pustulosis, arthralgia, musculoskeletal pain, myalgia, arthritis, increased muscle tension and spasms, joint swelling, myasthenia, muscle weakness, partial or complete tendon rupture, renal impairment, increased serum creatinine, acute renal failure, hematuria, crystalluria, interstitial nephritis, vaginal candidiasis, undiagnosed pain, discomfort, fever, asthenia, edema, sweating, gait disturbances, maculopapular rash, purpuric rash, injection site rash, injection site itching, injection site urticaria, aneurysm, aortic dissection, valvular regurgitation, valvular insufficiency, shock, hypotension, chest tightness, weakness, rhabdomyolysis, cough, interstitial pneumonia, abnormal chest X-ray, eosinophilia, vision impairment

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to protect it from air and moisture. Additionally, it is recommended to store the drug at room temperature between 1 to 30 degrees Celsius.

Appearance and packaging

Appearance

White round film-coated tablets

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.